SYS-CON MEDIA Authors: Doug Masi, Mat Mathews, PR.com Newswire, David Smith, Tim Crawford

News Feed Item

Spur Ventures Announces Granting of Stock Options

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 06/13/14 -- Spur Ventures Inc. ("Spur" or the "Company") (TSX VENTURE:SVU)(OTCBB:SPVEF) announces that the board of directors of the Company has approved the granting of 2,050,000 options pursuant to the Company Stock Option Plan to directors, officers and employees entitling them to purchase the common shares of the Company at a price in accordance with the pricing provisions of the Company's Stock Option Plan, being the average of the bid and ask prices of the Company on the TSX Venture Exchange during the three preceding trading days, of $0.32 per share until 5:00 p.m. (Vancouver time) June 13, 2019, with 12.5% vesting immediately and 12.5% each quarter over the next two (2) years, subject to regulatory approval.

These options represent the 2013 calendar year option allocation to directors, officers and employees which had been previously delayed due to the imposition of various blackout periods as the Company pursued a number of alternative corporate transactions. The Directors consider this to be the appropriate time to proceed with the 2013 stock option allocation as they believe that at this time there is no material undisclosed information in respect of the Company, the Transaction or any other potential corporate transactions.

On behalf of the Board of Directors

John Morgan, President and Chief Executive Officer

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contacts:
Spur Ventures Inc.
John Morgan
President and Chief Executive Officer
+1 604 689 5564

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.